Dyspepsia secondary prevention: Difference between revisions
Jump to navigation
Jump to search
m Bot: Removing from Primary care |
|||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Dyspepsia}} | {{Dyspepsia}} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} {{Ajay}} | ||
==Overview== | ==Overview== | ||
The secondary prevention strategies for dyspepsia following ''[[H. pylori]]'' infection to prevent recurrence of [[peptic ulcer disease]] and [[gastric cancer]] include the use of [[antibiotics]] to prevent recurrence of [[infection]] and the post-treatment confirmation of ''[[H. pylori]]'' eradication after treatment using diagnostic tests. | The [[secondary prevention]] strategies for dyspepsia following ''[[H. pylori]]'' infection to prevent recurrence of [[peptic ulcer disease]] and [[gastric cancer]] include the use of [[antibiotics]] to prevent recurrence of [[infection]] and the post-treatment confirmation of ''[[H. pylori]]'' eradication after treatment using diagnostic tests. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
[[Secondary prevention]] strategies for dyspepsia following ''[[H. pylori]]'' infection to prevent recurrence of [[peptic ulcer disease]] and [[gastric cancer]] include:<ref name="pmid21180520">{{cite journal| author=Lee YC, Liou JM, Wu MS, Wu CY, Lin JT| title=Eradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone. | journal=Therap Adv Gastroenterol | year= 2008 | volume= 1 | issue= 2 | pages= 111-20 | pmid=21180520 | doi=10.1177/1756283X08094880 | pmc=3002494 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21180520 }} </ref><ref name="pmid17170018">{{cite journal| author=Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D et al.| title=Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. | journal=Gut | year= 2007 | volume= 56 | issue= 6 | pages= 772-81 | pmid=17170018 | doi=10.1136/gut.2006.101634 | pmc=1954853 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17170018 }} </ref> | |||
:*Use of [[antibiotics]] to prevent recurrence of [[infection]] | :*Use of [[antibiotics]] to prevent recurrence of [[infection]] | ||
:*Post-treatment confirmation of ''[[H. pylori]]'' eradication after treatment using diagnostic tests | :*Post-treatment confirmation of ''[[H. pylori]]'' eradication after treatment using diagnostic tests | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
Latest revision as of 21:30, 29 July 2020
|
Dyspepsia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dyspepsia secondary prevention On the Web |
|
American Roentgen Ray Society Images of Dyspepsia secondary prevention |
|
Risk calculators and risk factors for Dyspepsia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ajay Gade MD[2]]
Overview
The secondary prevention strategies for dyspepsia following H. pylori infection to prevent recurrence of peptic ulcer disease and gastric cancer include the use of antibiotics to prevent recurrence of infection and the post-treatment confirmation of H. pylori eradication after treatment using diagnostic tests.
Secondary Prevention
Secondary prevention strategies for dyspepsia following H. pylori infection to prevent recurrence of peptic ulcer disease and gastric cancer include:[1][2]
- Use of antibiotics to prevent recurrence of infection
- Post-treatment confirmation of H. pylori eradication after treatment using diagnostic tests
References
- ↑ Lee YC, Liou JM, Wu MS, Wu CY, Lin JT (2008). "Eradication of helicobacter pylori to prevent gastroduodenal diseases: hitting more than one bird with the same stone". Therap Adv Gastroenterol. 1 (2): 111–20. doi:10.1177/1756283X08094880. PMC 3002494. PMID 21180520.
- ↑ Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D; et al. (2007). "Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report". Gut. 56 (6): 772–81. doi:10.1136/gut.2006.101634. PMC 1954853. PMID 17170018.